Send feedback

SUN2 p.Thr9Met

c.26C>T · rs149995796 · VCV1042816

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.1241 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0333%, amr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Emery-Dreifuss muscular dystrophy

Computational evidence

Protein change
AlphaMissense0.1241likely benign
REVEL0.127moderately benign-leaning
SaProtLLR -7.81tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.7GERP 2.1, phastCons 0.94
Regional constrainto/e 0.94unconstrained · MANE · 12 kb · p 0.11 · regional, not allelic
Overall
CADD23.3PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0333% Admixed American · 20/60,014 alleles
Filtering AF 0.0221% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0184%
Overall 0.00613% 99/1,613,962 alleles · ultra-rare exomes 73/1,461,598 · genomes 26/152,364 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0345% 2,902
Admixed Americangrpmax 0.0333% 3,001
Middle Eastern 0.033% 3,030
Remaining individualsnot grpmax-eligible 0.0112% 8,929
East Asian 0.00668% 14,959
European (non-Finnish) 0.00339% 29,500
South Asian 0.00329% 30,361
African / African-American 0.00266% 37,536

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SUN2
Protein
p.Thr9Met
Coding
c.26C>T
MANE Select
NM_015374
dbSNP
rs149995796
Type
single nucleotide variant
Location
chr22:38752603 (GRCh38)
Gene constraint
LOEUF 0.756 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 68.48 · 9 PDB
Residue 9
the 'lmna-binding' region; the 'disordered' region
Full SUN2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Emery-Dreifuss muscular dystrophy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Emery-Dreifuss muscular dystrophy (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, X-linked recessive
Onset
Childhood
Prevalence
1-9 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sun2-p-thr9met (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown